MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
In search of antiinflammatory drugs with a new mechanism of action, U0126 was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with an IC50 of 0.07 microM for MEK 1 and 0.06 microM for MEK 2. U0126 can undergo isomerization and cyclization reactions to form a variety of products, both chemically and in vivo, all of which exhibit less affinity for MEK and lower inhibition of AP-1 activity than parent, U0126.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ezh2 induction in juvenile wild-type islets exposed to PDGF-AA was blocked by U0126, which inhibits Erk1/2 activation23, but not by LY294002 or U-73122, inhibitors of PI3K or PLC-γ signalling (Supplementary Fig. 8a).”
From PDGF signalling controls age-dependent proliferation in pancreatic β-cells (2011) · cites this paper as [23]
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,015
Self-citationTransformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.
Zheng, C. F., & Guan, K. L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06361.x · Cited by 398
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309
DeSilva, D. R., Jones, E. A., Favata, M. F., Jaffee, B. D., Magolda, R. L., Trzaskos, J. M., & Scherle, P. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4175 · Cited by 295
Self-citationThe steroid receptor superfamily: mechanisms of diversity
Fuller, P. J. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1743440 · Cited by 200
Burgerʼs Medicinal Chemistry and Drug Discovery
Wolff, M. E. (1996) · American Journal of Therapeutics · doi:10.1097/00045391-199608000-00012 · Cited by 111
Cyanocarbon Chemistry. VIII.1 Heterocyclic Compounds from Tetracyanoethylene
Middleton, W. J., Engelhardt, V. A., & Fisher, B. S. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01544a058 · Cited by 70
Steroid hormone receptors: biochemistry, genetics, and molecular biology
Gehring, U. (1987) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(87)90195-2 · Cited by 44
Research works printed but not linked: 1
- Cano, 1995, TIBS, 117
Cited by
Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells
Vallier, L., Alexander, M., & Pedersen, R. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02553 · Cited by 947
“Interestingly, even addition of a high dose of FGF2 (40 ng/ml) did not decrease the quantity of Phospho-Smad1/5/8 localised in the nucleus, nor did addition of the SU inhibitor or the MEK kinase inhibitor UO126 (10 M) (Duncia et al., 1998) in combination with BMP4 increase it.”
BackgroundFeatures of Selective Kinase Inhibitors
Knight, Z. A., & Shokat, K. M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.011 · Cited by 657
“For example, the electrophilic natural product wortmannin has a half-life in tissue culture media of w10 min [56], whereas vinyl nitriles, such as those found in U0126, can undergo rearrangements on storage in DMSO [57].”
BackgroundTau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
“The RSKs also phosphorylate and inactivate GSK3 to stimulate translation (Eldar-Finkelman et al, 1995; Torres et al, 1999).”
Background
Metadata
- Authors
- Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., Teleha, C. A., Blom, K. F., Favata, M. F., Manos, E. J., Daulerio, A. J., Stradley, D. A., Horiuchi, K., Copeland, R. A., Scherle, P. A., Trzaskos, J. M., Magolda, R. L., Trainor, G. L., Wexler, R. R., Hobbs, F. W., & Olson, R. E.
- Affiliations
- DuPont (United States) (US)
- ORCID
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 8
- Issue
- 20
- Pages
- 2839-2844
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W2094114923
- Cited by
- 401
- References
- 11
- Citations by year
- 2026: 4 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 20 · 2020: 7 · 2019: 23 · 2018: 13 · 2017: 16 · 2016: 26 · 2015: 18 · 2014: 18 · 2013: 14 · 2012: 22
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Bioorganic & Medicinal Chemistry Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- U0126, MEK inhibitors, MEK1, MEK2, dual-specificity kinase, AP-1 transcriptional activity, non-competitive inhibition, isomerization, cyclization products, anti-inflammatory agents
- MeSH terms
- Animals, Anti-Inflammatory Agents, Biotransformation, Butadienes, Cyclization, Enzyme Inhibitors, Nitriles, NF-kappa B, Protein Serine-Threonine Kinases, Transcription Factor AP-1, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products. https://app.cochat.ai/papers/10.1016/s0960-894x(98)00522-8
- The paper
- Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., Teleha, C. A., Blom, K. F., Favata, M. F., Manos, E. J., Daulerio, A. J., Stradley, D. A., Horiuchi, K., Copeland, R. A., Scherle, P. A., . . . Olson, R. E. (1998). MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/s0960-894x(98)00522-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.